- Home
- NBH vs TSVT Comparison
NBH vs TSVT Comparison
Compare NBH & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBH
- TSVT
- Stock Information
- Founded
- NBH 2002
- TSVT 2021
- Country
- NBH United States
- TSVT United States
- Employees
- NBH N/A
- TSVT N/A
- Industry
- NBH Finance/Investors Services
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- NBH Finance
- TSVT Health Care
- Exchange
- NBH Nasdaq
- TSVT Nasdaq
- Market Cap
- NBH 291.1M
- TSVT 258.9M
- IPO Year
- NBH N/A
- TSVT N/A
- Fundamental
- Price
- NBH $9.85
- TSVT $4.98
- Analyst Decision
- NBH
- TSVT Buy
- Analyst Count
- NBH 0
- TSVT 4
- Target Price
- NBH N/A
- TSVT $6.50
- AVG Volume (30 Days)
- NBH 85.9K
- TSVT 1.1M
- Earning Date
- NBH 01-01-0001
- TSVT 05-07-2025
- Dividend Yield
- NBH 4.34%
- TSVT N/A
- EPS Growth
- NBH N/A
- TSVT N/A
- EPS
- NBH 0.12
- TSVT N/A
- Revenue
- NBH N/A
- TSVT $37,862,000.00
- Revenue This Year
- NBH N/A
- TSVT $84.48
- Revenue Next Year
- NBH N/A
- TSVT $9.69
- P/E Ratio
- NBH $87.04
- TSVT N/A
- Revenue Growth
- NBH N/A
- TSVT N/A
- 52 Week Low
- NBH $8.75
- TSVT $2.29
- 52 Week High
- NBH $11.01
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- NBH 35.83
- TSVT 76.79
- Support Level
- NBH $9.80
- TSVT $4.88
- Resistance Level
- NBH $9.98
- TSVT $4.99
- Average True Range (ATR)
- NBH 0.19
- TSVT 0.03
- MACD
- NBH -0.03
- TSVT -0.08
- Stochastic Oscillator
- NBH 36.19
- TSVT 90.91
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.